Adenosine regulation of the immune response initiated by ischemia reperfusion injury

Perfusion (United Kingdom)

Volumn 31, Issue 2, 2016, Pages 103-110

  Boros, D ^a   Thompson, J ^a   Larson, Douglas F ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

adenosine; cardioplegia; lymphocyte; macrophage; neutrophil; reperfusion

Indexed keywords

ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE; ARGINASE 1; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; T LYMPHOCYTE RECEPTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; ADENOSINE RECEPTOR; ANTIARRHYTHMIC AGENT; CARDIOTONIC AGENT;

CELL ACTIVATION; CELL ADHESION; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVATION; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; LYMPHOCYTE; MACROPHAGE ACTIVATION; MEDIATOR RELEASE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REPERFUSION INJURY; REVIEW; UPREGULATION; IMMUNOLOGY; MYOCARDIAL REPERFUSION INJURY;

ADENOSINE; ANTI-ARRHYTHMIA AGENTS; CARDIOTONIC AGENTS; HUMANS; MYOCARDIAL REPERFUSION INJURY; RECEPTORS, PURINERGIC P1;

EID: 84958953530     PISSN: 02676591     EISSN: 1477111X     Source Type: Journal    
DOI: 10.1177/0267659115586579     Document Type: Review

References (70)

1. Bae YS, Kim Y, Kim JH, Lee TG, Suh PG, Ryu SH,. Independent functioning of cytosolic phospholipase A2 and phospholipase D1 in Trp-Lys-Tyr-Met-Val-D-Met-induced superoxide generation in human monocytes. J Immunol 2000; 164: 4089-4096.
2. Headrick JP, Lasley RD,. Adenosine receptors and reperfusion injury of the heart. Handb Exp Pharmacol 2009; 189-214.
3. Mubagwa K, Flameng W,. Adenosine, adenosine receptors and myocardial protection: an updated overview. Cardiovasc Res 2001; 52: 25-39.
4. Foker JE, Einzig S, Wang T,. Adenosine metabolism and myocardial preservation. Consequences of adenosine catabolism on myocardial high-energy compounds and tissue blood flow. J Thorac Cardiovasc Surg 1980; 80: 506-516.
5. Chen GY, Nunez G,. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 2010; 10: 826-837.
6. Eltzschig HK, Eckle T,. Ischemia and reperfusion-from mechanism to translation. Nat Med 2011; 17: 1391-1401.
7. Hasko G, Kuhel DG, Chen JF, et al. Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms. FASEB J 2000; 14: 2065-2074.
8. Elliott MR, Chekeni FB, Trampont PC, et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 2009; 461: 282-286.
9. Chekeni FB, Elliott MR, Sandilos JK, et al. Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis. Nature 2010; 467: 863-867.
10. Robson SC, Wu Y, Sun X, Knosalla C, Dwyer K, Enjyoji K,. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation. Semin Thromb Hemost 2005; 31: 217-233.
11. Zimmermann H,. Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol 2000; 362: 299-309.
12. Eltzschig HK, Ibla JC, Furuta GT, et al. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J Exp Med 2003; 198: 783-796.
13. Sparks HV Jr., Bardenheuer H,. Regulation of adenosine formation by the heart. Circ Res 1986; 58: 193-201.
14. Barletta KE, Ley K, Mehrad B,. Regulation of neutrophil function by adenosine. Arterioscler. Thromb Vasc Biol 2012; 32: 856-864.
15. Martin C, Leone M, Viviand X, Ayem ML, Guieu R,. High adenosine plasma concentration as a prognostic index for outcome in patients with septic shock. Crit Care Med 2000; 28: 3198-3202.
16. Chen Y, Bache RJ,. Adenosine: a modulator of the cardiac response to stress. Circ Res 2003; 93: 691-693.
17. Hoskin DW, Mader JS, Furlong SJ, Conrad DM, Blay J,. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review). Int J Oncol 2008; 32: 527-535.
18. Liu GS, Thornton J, Van Winkle DM, Stanley AW, Olsson RA, Downey JM,. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 1991; 84: 350-356.
19. Cronstein BN, Daguma L, Nichols D, Hutchison AJ, Williams M,. The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively. J Clin Invest 1990; 85: 1150-1157.
20. Thiel M, Caldwell CC, Sitkovsky MV,. The critical role of adenosine A2A receptors in downregulation of inflammation and immunity in the pathogenesis of infectious diseases. Microbes Infect 2003; 5: 515-526.
21. Ahmad A, Ahmad S, Glover L, et al. Adenosine A2A receptor is a unique angiogenic target of HIF-2alpha in pulmonary endothelial cells. Proc Natl Acad Sci U. S. A. 2009; 106: 10684-10689.
22. Kong SW, Bodyak N, Yue P, et al. Genetic expression profiles during physiological and pathological cardiac hypertrophy and heart failure in rats. Physiol Genomics 2005; 21: 34-42.
23. Vinten-Johansen J, Thourani VH, Ronson RS, et al. Broad-spectrum cardioprotection with adenosine. Ann Thorac Surg 1999; 68: 1942-1948.
24. Huang S, Apasov S, Koshiba M, Sitkovsky M,. Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 1997; 90: 1600-1610.
25. Broussas M, Cornillet-Lefebvre P, Potron G, Nguyen P,. Inhibition of fMLP-triggered respiratory burst of human monocytes by adenosine: involvement of A3 adenosine receptor. J Leukoc Biol 1999; 66: 495-501.
26. Khoa ND, Montesinos MC, Reiss AB, Delano D, Awadallah N, Cronstein BN,. Inflammatory cytokines regulate function and expression of adenosine A(2A) receptors in human monocytic THP-1 cells. J. Immunol. 2001; 167: 4026-4032.
27. Feoktistov I, Biaggioni I,. Role of adenosine A(2B) receptors in inflammation. Adv Pharmacol 2011; 61: 115-144.
28. Morrison RR, Tan XL, Ledent C, Mustafa SJ, Hofmann PA,. Targeted deletion of A2A adenosine receptors attenuates the protective effects of myocardial postconditioning. Am J Physiol Heart Circ Physiol 2007; 293: H2523-H2529.
29. Lu Z, Fassett J, Xu X, et al. Adenosine A3 receptor deficiency exerts unanticipated protective effects on the pressure-overloaded left ventricle. Circulation 2008; 118: 1713-1721.
30. Sajjadi FG, Takabayashi K, Foster AC, Domingo RC, Firestein GS,. Inhibition of TNF-alpha expression by adenosine: role of A3 adenosine receptors. J Immunol 1996; 156: 3435-3442.
31. Lee HS, Chung HJ, Lee HW, Jeong LS, Lee SK,. Suppression of inflammation response by a novel A(3) adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-kappaB signaling. Immunobiology 2011; 216: 997-1003.
32. Bar-Yehuda S, Luger D, Ochaion A, et al. Inhibition of experimental auto-immune uveitis by the A3 adenosine receptor agonist CF101. Int J Mol Med 2011; 28: 727-731.
33. Fredholm BB, Irenius E, Kull B, Schulte G,. Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem Pharmacol 2001; 61: 443-448.
34. Fredholm BB,. Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ 2007; 14: 1315-1323.
35. Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J,. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 2001; 53: 527-552.
36. Thiel M, Chambers JD, Chouker A, et al. Effect of adenosine on the expression of beta(2) integrins and L-selectin of human polymorphonuclear leukocytes in vitro. J Leukoc Biol 1996; 59: 671-682.
37. Arslan F, Smeets MB, O'Neill LA, et al. Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody. Circulation 2010; 121: 80-90.
38. Corriden R, Insel PA,. New insights regarding the regulation of chemotaxis by nucleotides, adenosine, and their receptors. Purinergic Signal 2012; 8: 587-598.
39. Chen Y, Corriden R, Inoue Y, et al. ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 2006; 314: 1792-1795.
40. Mirakaj V, Thix CA, Laucher S, et al. Netrin-1 dampens pulmonary inflammation during acute lung injury. Am J Respir Crit Care Med 2010; 181: 815-824.
41. Aherne CM, Collins CB, Masterson JC, et al. Neuronal guidance molecule netrin-1 attenuates inflammatory cell trafficking during acute experimental colitis. Gut 2012; 61: 695-705.
42. Rosenberger P, Schwab JM, Mirakaj V, et al. Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat Immunol 2009; 10: 195-202.
43. Cronstein BN, Levin RI, Belanoff J, Weissmann G, Hirschhorn R,. Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. J Clin Invest 1986; 78: 760-770.
44. Sullivan GW, Lee DD, Ross WG, et al. Activation of A2A adenosine receptors inhibits expression of alpha 4/beta 1 integrin (very late antigen-4) on stimulated human neutrophils. J Leukoc Biol 2004; 75: 127-134.
45. Felsch A, Stocker K, Borchard U,. Phorbol ester-stimulated adherence of neutrophils to endothelial cells is reduced by adenosine A2 receptor agonists. J Immunol 1995; 155: 333-338.
46. van der Hoeven D, Wan TC, Gizewski ET, et al. A role for the low-affinity A2B adenosine receptor in regulating superoxide generation by murine neutrophils. J Pharmacol Exp Ther 2011; 338: 1004-1012.
47. Zhao ZQ, Sato H, Williams MW, Fernandez AZ, Vinten-Johansen J,. Adenosine A2-receptor activation inhibits neutrophil-mediated injury to coronary endothelium. Am J Physiol 1996; 271: H1456-H1464.
48. McColl SR, St-Onge M, Dussault AA, et al. Immunomodulatory impact of the A2A adenosine receptor on the profile of chemokines produced by neutrophils. FASEB J 2006; 20: 187-189.
49. Linden J, Cekic C,. Regulation of lymphocyte function by adenosine. Arterioscler Thromb Vasc Biol 2012; 32: 2097-2103.
50. Hesdorffer CS, Malchinkhuu E, Biragyn A, et al. Distinctive immunoregulatory effects of adenosine on T cells of older humans. FASEB J 2012; 26: 1301-1310.
51. Munoz E, Zubiaga AM, Merrow M, Sauter NP, Huber BT,. Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation. J Exp Med 1990; 172: 95-103.
52. Erdmann AA, Gao ZG, Jung U, et al. Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo. Blood 2005; 105: 4707-4714.
53. Ohta A, Sitkovsky M,. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 2001; 414: 916-920.
54. Ernst PB, Garrison JC, Thompson LF,. Much ado about adenosine: adenosine synthesis and function in regulatory T cell biology. J Immunol 2010; 185: 1993-1998.
55. Nowak M, Lynch L, Yue S, et al. The A2aR adenosine receptor controls cytokine production in iNKT cells. Eur J Immunol 2010; 40: 682-687.
56. Hasko G, Pacher P,. Regulation of macrophage function by adenosine. Arterioscler Thromb Vasc Biol 2012; 32: 865-869.
57. Biswas SK, Mantovani A,. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 2010; 11: 889-896.
58. Hasko G, Pacher P, Deitch EA, Vizi ES,. Shaping of monocyte and macrophage function by adenosine receptors. Pharmacol Ther 2007; 113: 264-275.
59. Szabo C, Scott GS, Virag L, et al. Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists. Br J Pharmacol 1998; 125: 379-387.
60. Hasko G, Szabo C, Nemeth ZH, Kvetan V, Pastores SM, Vizi ES,. Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J Immunol 1996; 157: 4634-4640.
61. Buenestado A, Grassin DS, Arnould I, et al. The role of adenosine receptors in regulating production of tumour necrosis factor-alpha and chemokines by human lung macrophages. Br J Pharmacol 2010; 159: 1304-1311.
62. Gordon S,. Alternative activation of macrophages. Nat Rev Immunol 2003; 3: 23-35.
63. Albina JE, Mills CD, Henry WL Jr., Caldwell MD,. Temporal expression of different pathways of 1-arginine metabolism in healing wounds. J Immunol 1990; 144: 3877-3880.
64. Csoka B, Selmeczy Z, Koscso B, et al. Adenosine promotes alternative macrophage activation via A2A and A2B receptors. FASEB J 2012; 26: 376-386.
65. Franke A, Lante W, Fackeldey V, et al. Pro-inflammatory cytokines after different kinds of cardio-thoracic surgical procedures: is what we see what we know? Eur J Cardiothorac Surg 2005; 28: 569-575.
66. Mentzer RM Jr., Myocardial protection in heart surgery. J Cardiovasc Pharmacol Ther 2011; 16: 290-297.
67. Jakobsen O, Naesheim T, Aas KN, Sorlie D, Steensrud T,. Adenosine instead of supranormal potassium in cardioplegia: it is safe, efficient, and reduces the incidence of postoperative atrial fibrillation. A randomized clinical trial. J Thorac Cardiovasc Surg 2013; 145: 812-818.
68. Onorati F, Santini F, Dandale R, et al. "Polarizing" microplegia improves cardiac cycle efficiency after CABG for unstable angina. Int J Cardiol 2013; 167: 2739-2746.
69. Whittaker P, Kloner RA, Przyklenk K,. Intramyocardial injections and protection against myocardial ischemia. An attempt to examine the cardioprotective actions of adenosine. Circulation 1996; 93: 2043-2057.
70. Day YJ, Li Y, Rieger JM, Ramos SI, Okusa MD, Linden J,. A2A adenosine receptors on bone marrow-derived cells protect liver from ischemia-reperfusion injury. J Immunol 2005; 174: 5040-5046.